Pages that link to "Q42944165"

The following pages link to Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. (Q42944165):

Displaying 39 items.

• Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis (Q24338938) (← links)
• Human leukocyte Antigen-DM polymorphisms in autoimmune diseases (Q26741035) (← links)
• HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism (Q27675409) (← links)
• Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice (Q28510157) (← links)
• The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes (Q30444065) (← links)
• SNP association mapping across the extended major histocompatibility complex and risk of B-cell precursor acute lymphoblastic leukemia in children (Q31133047) (← links)
• Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses (Q33707475) (← links)
• A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. (Q33772095) (← links)
• Antigen-processing machinery breakdown and tumor growth (Q34011098) (← links)
• Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation (Q34048781) (← links)
• Hijacking a chaperone: manipulation of the MHC class II presentation pathway (Q34091299) (← links)
• The control and facilitation of MHC class II antigen processing by the BCR. (Q34129320) (← links)
• HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. (Q34412690) (← links)
• Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques (Q34462167) (← links)
• HLA-DM, HLA-DO and tapasin: functional similarities and differences (Q34492989) (← links)
• Naive and memory B cells in T-cell-dependent and T-independent responses (Q34516552) (← links)
• HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation (Q34948997) (← links)
• Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy (Q35540109) (← links)
• The expression of HLA-DO (H2-O) in B lymphocytes (Q35794597) (← links)
• The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules (Q35821240) (← links)
• Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis (Q36083424) (← links)
• Right place, right time, right peptide: DO keeps DM focused (Q36266508) (← links)
• pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity (Q36323798) (← links)
• Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development (Q36370114) (← links)
• MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes (Q37189146) (← links)
• Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemia (Q37773238) (← links)
• MHC class II antigen presentation by dendritic cells regulated through endosomal sorting (Q38167996) (← links)
• DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms (Q39712353) (← links)
• Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. (Q40737770) (← links)
• Functional analysis of tryptophans alpha 62 and beta 120 on HLA-DM. (Q43802418) (← links)
• Antigen presentation on MHC molecules as a diversity filter that enhances immune efficacy (Q44555210) (← links)
• Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials (Q48171420) (← links)
• The HLA-DOB gene displays limited polymorphism with only one amino acid substitution (Q48272625) (← links)
• CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides. (Q48371221) (← links)
• Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DObeta (Q74241727) (← links)
• Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta (Q82661832) (← links)
• Synergy between B cell receptor/antigen uptake and MHCII peptide editing relies on HLA-DO tuning (Q90288626) (← links)
• HLA-DO Modulates the Diversity of the MHC-II Self-peptidome (Q90681131) (← links)
• Class II MHC antigen processing in immune tolerance and inflammation (Q93020630) (← links)